Comments

Aardvark Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Aardvark Therapeutics (AARD) operate in?

Aardvark Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

AARDNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.89

0.808.80%

At close: -

$10.73

0.848.49%

After Hours: May 8, 4:00 PM EDT

Q1 2025 Earnings were released on Wed May 14th, after the market close

Aardvark Therapeutics (AARD) Forecast

News Earnings Aardvark Therapeutics (AARD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Aardvark Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:AARD | Benzinga

Explore Aardvark Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AARD.

Open	$9.19
Close	$9.89
Volume / Avg.	19.15K / 120.39K
Day Range	$8.75 - $10.01
52 Wk Range	4.88 - 19.58
Market Cap	$229.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	2.51%
Days to Cover	5.19

Recent News

Why United Airlines Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

This Pulmonx Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$9.19
Close	$9.89
Volume / Avg.	19.15K / 120.39K
Day Range	$8.75 - $10.01
52 Wk Range	4.88 - 19.58
Market Cap	$229.45M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	51
Short Interest	2.51%
Days to Cover	5.19

About Aardvark Therapeutics Inc.

Sector

Health Care

Industry

Pharmaceuticals

Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel,...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Aardvark Therapeutics (AARD) stock?

You can purchase shares of Aardvark Therapeutics (NASDAQ:AARD) through any online brokerage.

View our list of the best stock brokerages

Who are Aardvark Therapeutics (AARD) competitors?

Other companies in Aardvark Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Third Harmonic Bio (NASDAQ:THRD), SNDL (NASDAQ:SNDL), Bioage Labs (NASDAQ:BIOA) and Rapport Therapeutics (NASDAQ:RAPP).

What is the forecast, or price target, for Aardvark Therapeutics (AARD) stock?

Aardvark Therapeutics has a consensus price target of $31.25.

What is the current price for Aardvark Therapeutics (AARD)?

The stock price for Aardvark Therapeutics (NASDAQ: AARD) is $10.73 last updated May 8, 2025 at 4:00 PM EDT.

Does Aardvark Therapeutics (AARD) pay a dividend?

There are no upcoming dividends for Aardvark Therapeutics.

When is Aardvark Therapeutics (NASDAQ:AARD) reporting earnings?

Aardvark Therapeutics’s Q2 earnings are confirmed for Thursday, August 14, 2025.

Is Aardvark Therapeutics (AARD) going to split?

There is no upcoming split for Aardvark Therapeutics.

What sector and industry does Aardvark Therapeutics (AARD) operate in?

Aardvark Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.